A clinical trial at UT Southwestern Medical Center aims to determine whether adding the hormone leptin to standard insulin therapy might help control the tumultuous blood-sugar levels of people with type 1 (insulin-dependent) diabetes...
I’ve been wearing the newest pump available from Minimed in the U.S., the Revel, for almost four months now. Minimed made it available to me through their temporary loaner pump program, and have kindly allowed me to hang on to it while I decide whether the Revel, an upgrade from the Minimed 522 I currently own, is worth the $400 that it costs to upgrade via their Paradigm Pathway Program.
From now through January 31, 2011, The New-York Historical Society will present the exhibition Breakthrough: The Dramatic Story of the Discovery of Insulin, recalling the desperate fight for life that used to be waged by juvenile diabetes patients, and commemorating the events of 1921 that inaugurated a new era of hope for them and their families.
Some days everything makes sense. You wake up high because of what you had for dinner the night before, or it was the late night snack, or you wake up…
If you’re looking for a feel-good, comfort food that won’t drive your blood sugar sky high like potatoes do, then this is it. This squash’s flesh is sunset orange, and its texture is smooth.
As I noted in my previous post, I recently took my diabetes with me on a trip to Tibet. (I offered to let it stay home, but it refused.) In addition to…
Spherix Inc., a biotechnology company based in Maryland, announced results of its NEET Phase 3 study of D-tagatose as a monotherapy for type 2 diabetes.
The NEET (Naturlose® Efficacy Evaluation Trial) data showed a significant drop in Hemoglobin A1c (HbA1c) levels among patients treated with D-tagatose....